NDC 50090-0481-01 - Naproxen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0481
- Requested NDC
- 50090-0481-01
- Package NDCs from labels
- 50090-0481-0, 50090-0481-7, 50090-0481-4, 50090-0481-5, 50090-0481-1, 50090-0481-9, 50090-0481-2, 50090-0481-6, 50090-0481-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-01-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen - A-S Medication Solutions | A-S Medication Solutions | 2026-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0481-0 | Naproxen | 15 in 1 BOTTLE | TABLET | 15 | 31 | |
| 50090-0481-1 | Naproxen | 20 in 1 BOTTLE | TABLET | 20 | 31 | |
| 50090-0481-2 | Naproxen | 30 in 1 BOTTLE | TABLET | 30 | 31 | |
| 50090-0481-4 | Naproxen | 14 in 1 BOTTLE | TABLET | 14 | 31 | |
| 50090-0481-5 | Naproxen | 40 in 1 BOTTLE | TABLET | 40 | 31 | |
| 50090-0481-6 | Naproxen | 100 in 1 BOTTLE | TABLET | 100 | 31 | |
| 50090-0481-7 | Naproxen | 60 in 1 BOTTLE | TABLET | 60 | 31 | |
| 50090-0481-9 | Naproxen | 6 in 1 BOTTLE | TABLET | 6 | 31 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0481 | NAPROXEN TABLET [A-S MEDICATION SOLUTIONS] | 29 | Current NDC, Legacy NDC, 8 package rows | 20240905_000155a8-709c-44e5-a75f-cd890f3a7caf.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0481-0 | EA - Each | 50090-0481 | b73d0457-aa5d-44d1-9ffe-8e84bc4b53d5 | 1 | 2018-09-05 |
| 50090-0481-1 | EA - Each | 50090-0481 | 8d86527d-2599-4a30-82a6-c2dbd1b98722 | 1 | 2018-09-05 |
| 50090-0481-2 | EA - Each | 50090-0481 | d92301e9-5ae9-43b2-b86b-e58dad9eaea9 | 1 | 2018-09-05 |
| 50090-0481-4 | EA - Each | 50090-0481 | 1442acf3-7793-4a96-8ebf-f200f2e60bce | 1 | 2018-09-05 |
| 50090-0481-5 | EA - Each | 50090-0481 | bac00d6f-6aa6-473b-a517-2d181646cda1 | 1 | 2018-09-05 |
| 50090-0481-6 | EA - Each | 50090-0481 | 3c8620e3-6f7e-46f4-a0de-5ad10fba1c21 | 1 | 2018-09-05 |
| 50090-0481-7 | EA - Each | 50090-0481 | 33b2100d-a17f-4f6d-bad0-120a73bada72 | 1 | 2018-09-05 |
| 50090-0481-9 | EA - Each | 50090-0481 | 08fbf0d0-348d-48a8-b1a1-760f87e60643 | 1 | 2018-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NAPROXEN SODIUM | NAPROXEN SODIUM | PuraCap Pharmaceutical LLC | fc865e81-164c-48e9-8fb9-6fc27d1c33cf | 2019-12-10 | Warnings | 9TN87S3A3C |
| NAPROXEN SODIUM | NAPROXEN SODIUM | Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd | 1d5981dd-e3f5-48a3-a5f1-ce49689cdfac | 2019-11-08 | Warnings | 9TN87S3A3C |
| Good Sense Naproxen Sodium | NAPROXEN SODIUM | Proficient Rx LP | c0dc7f87-355c-4357-b99d-f03693d350a7 | 2019-11-01 | Warnings | 9TN87S3A3C |
| Naproxen | NAPROXEN | Proficient Rx LP | 69a3afd6-d64b-4f07-b848-b0d3fc19f2a2 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | Cipla USA Inc. | e06c2b43-9882-442e-8413-10d9a33aecb9 | 2019-08-26 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen Caplets | NAPROXEN SODIUM 220 MG | Allegiant Health | 07120764-7c33-4c07-9367-40956d970c60 | 2019-06-06 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | SA3, LLC | 313dd447-4b9f-4e5b-8ca9-4a2a5a1a53d9 | 2019-04-23 | Boxed warning, Warnings, Adverse reactions | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | SUPERVALU INC | 1aedc0a1-466a-40c6-bb4c-53b7e8f83aff | 2018-12-17 | Warnings | 9TN87S3A3C |
| Naproxen Sodium 220mg | NAPROXEN SODIUM 220MG | Command Brands, LLC | 002052df-83ac-4efd-926c-b60a8f64cec4 | 2018-12-14 | Warnings | 9TN87S3A3C |
| Naproxen Sodium 220mg | NAPROXEN SODIUM 220MG | Athlete's Needs, Inc. | 84445187-8e57-4c0e-83c0-16b105a1cdd2 | 2018-12-12 | Warnings | 9TN87S3A3C |
| Naproxen Caplets All day relief for pain | NAPROXEN SODIUM 220 MG | Allegiant Health | 81ab5ec4-23c5-44da-b6c8-62f3d3077d48 | 2018-11-07 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | Premier Value Alliance LLC | 803b1569-46f0-4937-842c-0c363fe0ed79 | 2018-10-30 | Warnings | 9TN87S3A3C |
| NAPROXEN | NAPROXEN | TIME CAP LABORATORIES | 4350a2d9-5228-460e-b7b1-27e8fa846787 | 2018-10-09 | Warnings | 198014 198013 198012 57Y76R9ATQ |
| Naproxen | NAPROXEN | Aphena Pharma Solutions - Tennessee, LLC | e2347581-90da-429a-b17c-cffd0039fb86 | 2017-10-23 | Boxed warning, Warnings, Adverse reactions | 198014 198013 198012 57Y76R9ATQ |
| Naproxen | NAPROXEN | NCS HealthCare of KY, Inc dba Vangard Labs | 62a12771-bde9-4bc3-9ce9-672c8e31f020 | 2017-10-12 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| All Day Pain Relief | NAPROXEN SODIUM TABLETS, 220 MG | HealthLife of USA LLC | 7b0cb91e-5465-40ef-9f82-919f7d984f17 | 2017-06-01 | Warnings | 9TN87S3A3C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.